Santen Pharmaceutical. (4536.TSE) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
17
20
23
27

Details

Expected EPS
17
Actual EPS
25
Surprise EPS
8
Surprise Percent
+48.98%

Description

Santen Pharmaceutical. (4536.TSE) has reported earnings of 25 per share for Q2 2025.

0 Comments

Share your thoughts